N° 6422 – 5 rabii I 1437 (17-12-2015) BULLETIN OFFICIEL 4489
DÉNOMINATION COMMUNE INTERNATIONALE | DOSAGE | FORME D'ADMINISTRATION ---|---|--- Ifosfamide | 1 g | Injectable Ifosfamide | 2 g | Injectable Imatinib | 100 mg | Orale Nilotinib | 200 mg | Orale Sunitib | 12,5 mg | Orale Sunitib | 25 mg | Orale Sunitib | 50 mg | Orale Sorafenib | 200 mg | Orale Lapatinib | 250 mg | Orale Irinotecan | 40 mg | Injectable Irinotecan | 100 mg | Injectable Mesna | 400 mg | Injectable Mercaptopurine | 50 mg | Orale Mitoxantrone | 10 mg | Injectable Mitoxantrone | 20 mg | Injectable Mitoxantrone | 25 mg | Injectable Oxaliplatine | 50 mg | Injectable Oxaliplatine | 100 mg | Injectable Oxaliplatine | 200 mg | Injectable Paclitaxel | 30 mg | Injectable Paclitaxel | 150 mg | Injectable Paclitaxel | 100 mg | Injectable Paclitaxel | 300 mg | Injectable Pemetrexed | 100 mg | Injectable Pemetrexed | 500 mg | Injectable Raltitrexed | 2 mg | Injectable Temozolomide | 5 mg | Orale Temozolomide | 20 mg | Orale Temozolomide | 100 mg | Orale Temozolomide | 250 mg | Orale Trastuzumab | 150 mg | Injectable Triptoreline | 0,1 mg | Injectable